These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2009149)

  • 21. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
    Säynävälammi P
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive hormones in the renal response to systemic sepsis.
    Cumming AD; Driedger AA; McDonald JW; Lindsay RM; Solez K; Linton AL
    Am J Kidney Dis; 1988 Jan; 11(1):23-32. PubMed ID: 3276170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
    Watson ML; Macnicol AM; Allan PL; Wright AF
    Kidney Int; 1992 Jan; 41(1):206-10. PubMed ID: 1317477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
    Favre L; Jornot L; Riondel A; Vallotton M
    Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
    Pérez-Ayuso RM; Arroyo V; Camps J; Rimola A; Costa J; Gaya J; Rivera F; Rodés J
    Hepatology; 1984; 4(2):247-52. PubMed ID: 6368354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.
    Harvey JN; Edmundson AW; Jaffa AA; Martin LL; Mayfield RK
    Diabetologia; 1992 Sep; 35(9):857-62. PubMed ID: 1397781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of TXB2 after angiotensin converting enzyme inhibition in hypertensive patients.
    Kudo K; Abe K; Chiba S; Omata K; Sato K; Yasugima M; Sato M; Yoshinaga K
    Prostaglandins Leukot Med; 1986 Jan; 21(1):77-86. PubMed ID: 3006084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cicletanine on the urinary excretion of prostanoids and kallikrein, and on renal function in man.
    Tsunoda K; Abe K; Omata K; Hagino T; Minami N; Munakata M; Yoshida K; Sakuma H; Misawa S; Arima S
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):253-6. PubMed ID: 8357779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy.
    Shiba T; Inoue M; Tada H; Hayashi Y; Okuda Y; Fujita R; Makino F; Takahasi C; Kageyama S; Kitamura S; Iwamoto Y
    Diabetes Res Clin Pract; 2000 Feb; 47(2):97-104. PubMed ID: 10670908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension.
    Franchi F; Lo Sapio P; Strazzulla G; Fabbri G; Scardi A; Pinzani M; Laffi G; Mannelli M
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):44-9. PubMed ID: 3549580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The investigation about age-related changes in vasoactive substances of normal subjects and of patients with essential hypertension].
    Hou J; Abe K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):287-93. PubMed ID: 1630030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.